Important: Help to manage your eye health during the COVID-19 pandemic. Learn more >Close Covid Alert

Wet Age-related Macular Degeneration Wet Age-related Macular Degeneration

If you have Wet AMD – Take control of your sight with EYLEA


Keep living life through your eyes

Wet Age-related Macular Degeneration (Wet AMD) can impact your eyes—and how you see life. EYLEA is clinically proven to help improve vision—which may help you read letters and see details more clearly.* In clinical trials, patients’ vision was tracked for 4 years, and EYLEA was shown to maintain a majority of vision improvements with continued treatments.

*These are results from two clinical studies; your individual results may vary.

Wet AMD can impact your vision. Take control of your sight with EYLEA.
Wet AMD affects the macula, which is located in the back of the eye, and can cause symptoms like black spots, blurriness, or wavy lines. Wet AMD is the leading cause of vision loss among people 50 years of age and older in the United States.

Help fight back with EYLEA

EYLEA can help Wet AMD

Maintain and Improve Vision
EYLEA is clinically proven to help improve vision—which could help your ability to read letters more clearly.*
8.5 More Letters
EYLEA has been shown to enable people with Wet AMD to see nearly two additional rows of letters on an eye chart.

On average, among all dosing groups in 2 clinical studies.

94% of patients
In studies, 94% of EYLEA patients maintained their vision after 1 year.
Number one FDA Approved
EYLEA is the #1 FDA-approved treatment in its class for patients with Wet AMD.

*These are results from two clinical studies; your individual results may vary.

IBM Truven MarketScan data: Number of injections administered, from Q4 2018 through Q3 2019; Data on File.

EYLEA® (aflibercept) Injection is a prescription medicine administered by injection into the eye. You should not use EYLEA if you have an infection in or around the eye, eye pain or redness, or known allergies to any of the ingredients in EYLEA, including aflibercept.

FINANCIAL SUPPORT FROM EYLEA4U®

TIPS FOR LIVING WITH LOW VISION

SAFETY INFO FOR EYLEA

EYLEA4U® logo

EYLEA4U is a comprehensive support program with several resources available to help eligible patients with the cost of EYLEA.

Tips for living with low vision

Just a few changes may make a big difference in your daily routine.

EYLEA safety information

Read about possible side effects, what you should tell your doctor before you receive EYLEA, and more.

Frequently asked questions about Wet Age-related Macular Degeneration

FREQUENTLY ASKED QUESTIONS

Have questions about EYLEA or Wet AMD? We have answers.

See the FAQs

Watch Teresa’s experience with EYLEA.

IMPORTANT SAFETY INFORMATION
  • EYLEA® (aflibercept) Injection is a prescription medicine administered by injection into the eye. You should not use EYLEA if you have an infection in or around the eye, eye pain or redness, or known allergies to any of the ingredients in EYLEA, including aflibercept.
  • Injections into the eye with EYLEA can result in an infection in the eye and retinal detachment (separation of retina from back of the eye) can occur. Inflammation in the eye has been reported with the use of EYLEA.
  • In some patients, injections with EYLEA may cause a temporary increase in eye pressure within 1 hour of the injection. Sustained increases in eye pressure have been reported with repeated injections, and your doctor may monitor this after each injection.
  • There is a potential but rare risk of serious and sometimes fatal side effects, related to blood clots, leading to heart attack or stroke in patients receiving EYLEA.
  • The most common side effects reported in patients receiving EYLEA were increased redness in the eye, eye pain, cataract, vitreous (gel-like substance) detachment, vitreous floaters, moving spots in the field of vision, and increased pressure in the eye.
  • You may experience temporary visual changes after an EYLEA injection and associated eye exams; do not drive or use machinery until your vision recovers sufficiently.
  • Contact your doctor right away if you think you might be experiencing any side effects, including eye pain or redness, light sensitivity, or blurring of vision, after an injection.
  • For additional safety information, please talk to your doctor and see the full Prescribing Information for EYLEA.

You are encouraged to report negative side effects of prescription drugs to the FDA.
Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

INDICATIONS

EYLEA® (aflibercept) Injection 2 mg (0.05mL) is a prescription medicine approved for the treatment of patients with Wet Age-related Macular Degeneration (AMD), Macular Edema following Retinal Vein Occlusion (RVO), Diabetic Macular Edema (DME), and Diabetic Retinopathy (DR).

Please see the full Prescribing Information for EYLEA.

The information contained herein is provided for general educational purposes. If you have any questions, talk to your doctor.

For U.S. Residents Only

EYLEA AND EYLEA4U are registered trademarks of Regeneron Pharmaceuticals, Inc.

© 2021, Regeneron Pharmaceuticals, Inc. All rights reserved.
777 Old Saw Mill River Road,
Tarrytown, NY 10591

01/2021
EYL.20.10.0071 EYL.20.10.0071

 

Searching with Lea

Close
MENU